01 5Rinvoq
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 731
2019 Revenue in Millions : 47
Growth (%) : 1,455
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 1,651
2020 Revenue in Millions : 731
Growth (%) : 126
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 2,522
2021 Revenue in Millions : 1,651
Growth (%) : 53
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 3,969
2022 Revenue in Millions : 2,522
Growth (%) : 57
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 47
2018 Revenue in Millions : 0
Growth (%) : New launch
LOOKING FOR A SUPPLIER?